Description
Cenforce (Sildenafil) 150 mg
Cenforce 150 mg is identified by the product name as a sildenafil-containing medicine. Sildenafil is a prescription phosphodiesterase type 5 (PDE5) inhibitor used for erectile dysfunction in adult men. The trade name “Cenforce” itself could not be verified from official regulatory sources, so the summary below is based on the consistently verified active ingredient, sildenafil.
Active Ingredient and Medicine Class
Active ingredient: sildenafil.
Medicine class: phosphodiesterase type 5 (PDE5) inhibitor. This class also includes other erectile dysfunction medicines, but sildenafil has its own established safety profile and interaction warnings.
Established Medical Uses
Sildenafil is established for the treatment of erectile dysfunction in adult men, meaning difficulty achieving or maintaining an erection sufficient for satisfactory sexual activity. Regulatory sources also describe its use in patients with erectile dysfunction of organic, psychogenic, or mixed causes.
How It Works
Sildenafil inhibits PDE5, an enzyme involved in the breakdown of cyclic guanosine monophosphate (cGMP). By preserving cGMP activity in penile tissue, it helps relax smooth muscle and increase blood flow during sexual stimulation, which supports erection. It does not directly cause an erection without sexual stimulation.
Important Safety Information
Sildenafil is contraindicated with nitrates or other nitric oxide donors because the combination can cause a marked drop in blood pressure. It should also not be used with riociguat. Caution is needed with alpha-blockers and other blood-pressure-lowering medicines because of additive hypotensive effects. Important warnings also include patients with a history of sudden vision loss related to non-arteritic anterior ischemic optic neuropathy, and caution in people with certain eye disorders such as retinitis pigmentosa.
Possible Side Effects
Common adverse effects include headache, flushing, indigestion, nasal congestion, and visual disturbance such as altered colour vision or blurred vision. More serious but less common reactions can include priapism, severe low blood pressure, sudden hearing loss, and sudden loss of vision.
Scientific Evidence
Randomized trials and systematic reviews show that sildenafil is more effective than placebo for improving erections and successful intercourse in men with erectile dysfunction. Review data also show that the most frequent harms are generally transient and mild to moderate, although clinically important cardiovascular and visual risks are recognised in labeling and post-marketing surveillance.
Medical Information Notice
This page is an educational summary based on sources available at the time of review. It does not replace the official patient leaflet or assessment by a qualified healthcare professional.
Medical Sources
- European Medicines Agency (EMA) — Viagra: EPAR
- DailyMed — Sildenafil Tablets, Prescribing Information
- Langtry HD, Markham A. “Sildenafil: a review of its use in erectile dysfunction.” Drugs. 1999. PubMed
